Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2025-12-25 @ 1:45 AM
NCT ID:
NCT04438694
Eligibility Criteria:
Inclusion Criteria:
* Must have laboratory confirmed COVID-19 and admitted to Cairo University isolation hospital.
* Admitted to acute care facility.
* Must have severe or immediately life-threatening COVID-19:
Severe disease is defined as:
* dyspnea,
* respiratory frequency ≥ 30/min,
* blood oxygen saturation ≤ 93%,
* partial pressure of arterial oxygen to fraction of inspired oxygen ratio \<300, and/or
* lung infiltrates \> 50% within 24 to 48 hours (CT finding)
Life-threatening disease is defined as:
* respiratory failure,
* septic shock, and/or
* multiple organ dysfunction or failure
Exclusion Criteria:
* Pregnancy
* Autoimmune disorder
* Participated in a CP trial in the past 6 months
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
70 Years
Study:
NCT04438694
Study Brief:
Protocol Section:
NCT04438694